Gélinas C - Search Results

1

Transcriptional activity of rel family proteins.

McDonnell PC, Kumar S, Rabson AB, Gélinas C. McDonnell PC, et al. Among authors: gelinas c. Oncogene. 1992 Jan;7(1):163-70. Oncogene. 1992. PMID: 1741161

2

The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Kumar S, Rabson AB, Gélinas C. Kumar S, et al. Among authors: gelinas c. Mol Cell Biol. 1992 Jul;12(7):3094-106. doi: 10.1128/mcb.12.7.3094-3106.1992. Mol Cell Biol. 1992. PMID: 1620118 Free PMC article.

3

Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.

Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F, Gélinas C, Rabson AB. Thakur S, et al. Among authors: gelinas c. Oncogene. 1994 Aug;9(8):2335-44. Oncogene. 1994. PMID: 8036016

4

The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.

Inuzuka M, Ishikawa H, Kumar S, Gélinas C, Ito Y. Inuzuka M, et al. Among authors: gelinas c. Oncogene. 1994 Jan;9(1):133-40. Oncogene. 1994. PMID: 8302572

5

Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.

Ishikawa H, Asano M, Kanda T, Kumar S, Gélinas C, Ito Y. Ishikawa H, et al. Among authors: gelinas c. Oncogene. 1993 Nov;8(11):2889-96. Oncogene. 1993. PMID: 8414493

6

I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif.

Kumar S, Gélinas C. Kumar S, et al. Among authors: gelinas c. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8962-6. doi: 10.1073/pnas.90.19.8962. Proc Natl Acad Sci U S A. 1993. PMID: 8415639 Free PMC article.

7

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells.

Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gélinas C, Rabson AB. Suh J, et al. Among authors: gelinas c. Prostate. 2002 Aug 1;52(3):183-200. doi: 10.1002/pros.10082. Prostate. 2002. PMID: 12111695

8

Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.

Fan Y, Rayet B, Gélinas C. Fan Y, et al. Among authors: gelinas c. Oncogene. 2004 Feb 5;23(5):1030-42. doi: 10.1038/sj.onc.1207221. Oncogene. 2004. PMID: 14647412

9

A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.

Xu X, Gélinas C. Xu X, et al. Among authors: gelinas c. Oncogene. 1997 Apr 3;14(13):1521-30. doi: 10.1038/sj.onc.1200985. Oncogene. 1997. PMID: 9129142

10

v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.

Zong WX, Farrell M, Bash J, Gélinas C. Zong WX, et al. Among authors: gelinas c. Oncogene. 1997 Aug 18;15(8):971-80. doi: 10.1038/sj.onc.1201266. Oncogene. 1997. PMID: 9285692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters